Abiopharma

New Form 8-K - Kalaris Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143202 Size: 143 KB Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Item 8.01: Other Events